CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
48 hedge funds and large institutions have $83.1M invested in Crescent Biopharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 5 closing their positions.
Holders
48
Holders Change
+13
Holders Change %
+37.14%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
8
Reduced
13
Closed
5
Calls
$1.04M
Puts
$5K
Net Calls
+$1.04M
Net Calls Change
+$1.03M